Riboflavin (vitamin B2)
Also called: vitamin B2, riboflavin 5'-phosphate
A water-soluble B vitamin that forms the coenzymes FMN and FAD, which support energy production and the metabolism of fats, drugs and steroids. Food sources include eggs, organ meats, lean meats, milk and dairy, and fortified grains and cereals.
- Category
- Vitamin
- Forms
- Free riboflavin (most supplements); riboflavin 5'-phosphate
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2026 meta-analysis (J Res Med Sci) included 12 trials (749 people with migraine) of oral riboflavin alone; its table lists 7 as randomized. Its riboflavin-versus-control analysis pooled 7 controlled studies, at least 5 of them randomized. [2]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BBrain, mood and sleep2 topics
CCancer1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Migraine frequency in adults | B | A randomized trial in 55 adults found 400 mg/day reduced attacks by two per month versus placebo. Neurology societies rate riboflavin probably effective for migraine prevention. [1] |
| Migraine in children and adolescents | C | A retrospective study of 41 children (200 or 400 mg/day, 3–6 months) reported fewer attacks, but two small randomized trials (50–200 mg/day) found no reduction versus placebo. [1] |
| Cancer risk | C | Cohort studies are mixed: some found inverse associations (lung cancer in current smokers; colorectal cancer in postmenopausal women), others none. ODS states clinical trials are needed. [1] |
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- RDA, adults 19+: men 1.3 mg; women 1.1 mg; pregnancy 1.4 mg; lactation 1.6 mg. [1]
- Migraine studies used 400 mg/day (adults) and 50–400 mg/day (children); the Canadian Headache Society recommends 400 mg/day for migraine prevention. [1]
Upper limits
- No UL: the Food and Nutrition Board did not establish ULs for riboflavin. [1]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingODS states that riboflavin deficiency during pregnancy can increase the risk of preeclampsia, and that the limited evidence on the benefits of …
2 statements in the profile.
Details and sources - Interactions with medicinesNone reported
Medications (none named): ODS states that riboflavin is not known to have any clinically relevant interactions with medications.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications8 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Food intakes many times the RDA have no observable toxicity, and no adverse effects have been reported from 400 mg/day for at least 3 months; the Food and Nutrition Board still urges caution with excessive amounts. [1]
- Riboflavin is not known to have any clinically relevant interactions with medications. [1]
- Groups at risk of inadequacy: vegetarian athletes; pregnant or lactating women who rarely eat meat or dairy; vegans and people who consume little milk; people with riboflavin transporter deficiency. [1]
Identity, quality and standardization
- Most supplements contain riboflavin in the free form; some contain riboflavin 5'-phosphate. [1]
Regulatory status
- US: available in dietary supplements; grains and cereals are fortified with riboflavin. The FDA Daily Value is 1.3 mg for adults and children age 4 years and older. [1]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 8 entries naming riboflavin or vitamin B-2 (6 name riboflavin or riboflavin 5'-phosphate; 2 list only "Vitamin B-2"), NDI 491 to NDI 508, all submitted 2007-12-03. All 8 are multi-ingredient vitamin combinations. Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Medications (none named): ODS states that riboflavin is not known to have any clinically relevant interactions with medications. [P1]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test of the dietary ingredient (at least one appropriate test or examination) — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petitioned under 111.75(a)(1)(ii). [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- About 95% of riboflavin in the form of FAD or FMN from food is bioavailable, up to a maximum of about 27 mg of riboflavin per meal or dose; the body absorbs little riboflavin from single doses beyond 27 mg. [P1]
- Most riboflavin is absorbed in the proximal small intestine; the body stores only small amounts, in the liver, heart and kidneys. [P1]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
Sources for this profile
- NIH Office of Dietary Supplements. Riboflavin: Fact Sheet for Health Professionals (updated May 11, 2022), 2022-05-11. ods.od.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (agents classified by the IARC Monographs; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
Sources
- NIH Office of Dietary Supplements. Riboflavin: Fact Sheet for Health Professionals (updated May 11, 2022), 2022-05-11. ods.od.nih.gov
- Amini S, et al. The effect of riboflavin on the mean attack frequency, severity, and duration of migraine headaches: a systematic review and dose-response meta-analysis of clinical trials. J Res Med Sci 2026;31:1 (PMID 41769676), 2026-01-31. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in vitamin: Benfotiamine · Biotin · Folate (folic acid) · Methylfolate (L-5-MTHF) · Niacin (vitamin B3) · Nicotinamide riboside · Pantothenic acid (vitamin B5) · Thiamin (vitamin B1) · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.